NeuroFlexor provides a more sensitive and reliable description of the spasticity components compared to other clinical measures used today. This makes NeuroFlexor useful in research studies evaluating spasticity profiles and effectiveness of anti-spasticity treatments. Please follow the links below for more information.

PubMed listings

Early papers -2014

Stubbs P, Figlewski K, Nielsen JF. Objective Quantification of Wrist and Finger Spasticity: An Alternative to Current Clinical Measurements: A Commentary. J Nov Physiother 4:220. doi: 10.4172/2165-7025.1000220

Zetterberg H, Frykberg GE, Gäverth J, Lindberg PG. Neural and Nonneural Contributions to Wrist Rigidity in Parkinson’s Disease: An Explorative Study Using the NeuroFlexor. BioMed Res Int. E-pub ahead of print. 

Gäverth J, Eliasson AC, Kullander K, Borg J, Lindberg PG, Forssberg H. Sensitivity of the NeuroFlexor method to measure change in spasticity after treatment with botulinum toxin A in wrist and finger muscles. J Rehabil Med. 2014;46:629-34.

Lindberg PG, Gäverth J, Islam M, Fagergren A, Borg J, Forssberg H. Validation of a new biomechanical model to measure muscle tone in spastic muscles. Neurorehabil Neural Repair. 2011;25(7):617–625

Lindberg P, Borg J. Central pares – nya diagnostiska och terapeutiska möjligheter. Incitament. 2011;20:369–373 [Swedish]

Gäverth J, Sandgren M, Lindberg PG, Forssberg H, Eliasson A-C. Test-retest and inter-rater reliability of a method to measure wrist and finger spasticity. J Rehabil Med 2013;45:630-636